Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Schaffer

Showing results (261-270 of 4,760) with videos related to

Pageof 476
Sort By:
Molecular and Cellular Biology|August 1, 1985
Activation of immediate-early, early, and late promoters by temperature-sensitive and wild-type forms of herpes simplex virus type 1 protein ICP4N A DeLuca, P A Schaffer
Sante Publique (Vandoeuvre-Les-Nancy, France)|September 16, 2000
[Cervical cancer screening in the Bas-Rhin. Evaluation of four and a half years of the EVE campaign]M Fender, P Schaffer, P Dellenbach
Journal of Virology|March 10, 2001
ICP0 is required for efficient reactivation of herpes simplex virus type 1 from neuronal latencyW P Halford, P A Schaffer
Journal of Epidemiology and Biostatistics|February 8, 2002
Relative survival: comparison of regressive models and advice for the userR Giorgi, G Hédelin, P Schaffer
Cell|March 19, 2011
Network news: innovations in 21st century systems biologyAdam P Arkin, David V Schaffer
Biochimica Et Biophysica Acta|April 13, 1990
Defective sarcolemmal phosphorylation associated with noninsulin-dependent diabetesS N Allo, S W Schaffer
Applied Optics|June 22, 2010
High-speed pattern projection for three-dimensional shape measurement using laser specklesMartin Schaffer, Marcus Grosse, Richard Kowarschik
Frontiers in Microbiology|November 9, 2011
Enhancing the Clinical Potential of AAV Vectors by Capsid Engineering to Evade Pre-Existing ImmunityMelissa Bartel, David Schaffer, Hildegard Büning
Frontiers in Bioscience (Landmark Edition)|December 29, 2011
H₄ receptors in mast cells and basophils: a new therapeutic target for allergy?Bernhard F Gibbs, Francesca Levi-Schaffer
Pharmaceutical Research|August 10, 2011
Antiviral RNAi: translating science towards therapeutic successPriya S Shah, David V Schaffer
Pageof 476

Showing results (261-270 of 4,760) with videos related to

Sort By:
Pageof 476
Molecular and Cellular Biology|August 1, 1985
Activation of immediate-early, early, and late promoters by temperature-sensitive and wild-type forms of herpes simplex virus type 1 protein ICP4N A DeLuca, P A Schaffer
Sante Publique (Vandoeuvre-Les-Nancy, France)|September 16, 2000
[Cervical cancer screening in the Bas-Rhin. Evaluation of four and a half years of the EVE campaign]M Fender, P Schaffer, P Dellenbach
Journal of Virology|March 10, 2001
ICP0 is required for efficient reactivation of herpes simplex virus type 1 from neuronal latencyW P Halford, P A Schaffer
Journal of Epidemiology and Biostatistics|February 8, 2002
Relative survival: comparison of regressive models and advice for the userR Giorgi, G Hédelin, P Schaffer
Cell|March 19, 2011
Network news: innovations in 21st century systems biologyAdam P Arkin, David V Schaffer
Biochimica Et Biophysica Acta|April 13, 1990
Defective sarcolemmal phosphorylation associated with noninsulin-dependent diabetesS N Allo, S W Schaffer
Applied Optics|June 22, 2010
High-speed pattern projection for three-dimensional shape measurement using laser specklesMartin Schaffer, Marcus Grosse, Richard Kowarschik
Frontiers in Microbiology|November 9, 2011
Enhancing the Clinical Potential of AAV Vectors by Capsid Engineering to Evade Pre-Existing ImmunityMelissa Bartel, David Schaffer, Hildegard Büning
Frontiers in Bioscience (Landmark Edition)|December 29, 2011
H₄ receptors in mast cells and basophils: a new therapeutic target for allergy?Bernhard F Gibbs, Francesca Levi-Schaffer
Pharmaceutical Research|August 10, 2011
Antiviral RNAi: translating science towards therapeutic successPriya S Shah, David V Schaffer
Pageof 476